Syracuse Stage closes ‘Matilda the Musical’ due to breakthrough infections
SYRACUSE — Syracuse Stage will close its production of “Matilda the Musical,” effective immediately, and will not reopen due to multiple breakthrough cases of COVID-19 in the company.
Syracuse Stage will contact ticketholders directly. Ticketholders can also contact the Syracuse Stage Box Office at 315-443-3275, Monday through Friday, 10 a.m. to 5 p.m., to arrange for refunds or to discuss other options. Following positive COVID test results affecting multiple company members, Syracuse Stage senior management, in consultation with the Syracuse Stage Board of Trustees executive committee, determined that discontinuing performances was the safest and most responsible course of action for the cast, crew, staff and patrons.
“With COVID cases surging locally and nationally and with the arrival of the highly contagious Omicron variant, the risk of further spread within the company and to patrons was deemed too great,” said Jill Anderson, managing director. “Our first priority has always been the health and safety of our artists, staff and audience. Recent breakthrough cases among our company make proceeding impossible.”
Unlike with “Eureka Day,” an on demand option will not be available for “Matilda the Musical.” Syracuse Stage’s licensing agreement prohibits recording and distributing the show online.
The pandemic continues to impact theaters across the country. Broadway, Off-Broadway, touring companies and regional theaters have all experienced closures or temporary halts to performances. Robert Hupp, artistic director, said that Stage intends to continue with live theater throughout the remainder of the season beginning with the comedy “Yoga Play,” scheduled to run Jan. 19 through Feb. 6.
“While we are heartbroken that we can’t continue to welcome patrons to ‘Matilda,’ we have a greater responsibility to our people and our community,” said Hupp. “We thank everyone who joined us for our holiday production and we look forward to gathering again safely in the future.”
No comments on this item Please log in to comment by clicking here